For: | Hamasaki H, Hamasaki Y. Efficacy of anagliptin as compared to linagliptin on metabolic parameters over 2 years of drug consumption: A retrospective cohort study. World J Diabetes 2018; 9(10): 165-171 [PMID: 30364744 DOI: 10.4239/wjd.v9.i10.165] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v9/i10/165.htm |
Number | Citing Articles |
1 |
Gevorg G. Danagulyan, Henrik A. Panosyan, Vache K. Gharibyan, Ani H. Hasratyan. A Simple and Easily Implemented Method for the Regioselective Introduction of Deuterium into Azolo[1,5-a]pyrimidines Molecules. Molecules 2023; 28(6): 2869 doi: 10.3390/molecules28062869
|
2 |
A.B.M. Kamrul-Hasan, Deep Dutta, Lakshmi Nagendra, Meha Sharma, Shinjan Patra, Saptarshi Bhattacharya. Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis. Medicine 2024; 103(28): e38870 doi: 10.1097/MD.0000000000038870
|
3 |
Г. Г. Данагулян, В. К. Гарибян. Спектр биологической активности произ-водных пиразоло[1,5-а]пиримидина и пути их модификации (обзор). Chemical Journal of Armenia 2023; : 77 doi: 10.54503/0515-9628-2023.76.1-2-77
|
4 |
Agnieszka Jankowska, Anna Wesołowska, Maciej Pawłowski, Grażyna Chłoń-Rzepa. Diabetic Theory in Anti-Alzheimer’s Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents. Current Medicinal Chemistry 2020; 27(39): 6658 doi: 10.2174/0929867326666191011144818
|